Concepedia

Enda Shevlin

ES

Statistics

Publications

7

Citations

469

H-Index

7

Active since

2013

Affiliations

Cornell University(Current)

National University of Ireland, Maynooth

Molecular Innovations (United States)

Weill Cornell Medicine

Enda Shevlin is an author at Cornell University specializing in immunology, chimeric antigen receptor t-cell therapy, and oncology.

Publications per year

2013–2020

7

Publications

7

Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity

Spencer Park, Enda Shevlin, Yogindra Vedvyas et al. · Scientific Reports · 2017 · 167 citations · Full text

Medicine, Immunology, Oncology +17

CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors

Irene M. Min, Enda Shevlin, Yogindra Vedvyas et al. · Clinical Cancer Research · 2017 · 99 citations

Medicine, Immunology, Oncology +12

Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors

Yogindra Vedvyas, Enda Shevlin, Marjan Zaman et al. · JCI Insight · 2016 · 90 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer

Katherine D. Gray, Jaclyn E. McCloskey, Yogindra Vedvyas et al. · Clinical Cancer Research · 2020 · 49 citations · Full text

Medicine, Immunology, Oncology +17

TRIF-Mediated TLR3 and TLR4 Signaling Is Negatively Regulated by ADAM15

Suaad Ahmed, Ashwini Maratha, Aisha Qasim Butt et al. · The Journal of Immunology · 2013 · 37 citations

Life Sciences, Immunology, Molecular Biology +17

1–5 of 7